Coadministration of scopolamine and mGlu2 NAM VU6001966 as a novel antidepressant approach: Lowering effective dose and reducing cognitive side effects.
Authors: Babii Y, Pałucha-Poniewiera A, Bobula B, Kania A, Bederska-Łojewska D, Brański P, Pilc A
Journal: Psychopharmacology
suicide prevention
mental health
open access